Pages that link to "Q47263400"
Jump to navigation
Jump to search
The following pages link to Incidence of hepatitis A in the United States in the era of vaccination (Q47263400):
Displaying 50 items.
- Dissecting the indirect effects caused by vaccines into the basic elements (Q26799527) (← links)
- Arsenic exposure and the seroprevalence of total hepatitis A antibodies in the US population: NHANES, 2003-2012 (Q28393717) (← links)
- Enigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter? (Q28657724) (← links)
- Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A. (Q33265523) (← links)
- Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study (Q33289925) (← links)
- The costs of hepatitis A infections in South Korea. (Q34132167) (← links)
- Diagnosis of hepatitis a virus infection: a molecular approach (Q34334021) (← links)
- Seroprevalence of hepatitis a and associated socioeconomic factors in young healthy korean adults (Q34725927) (← links)
- Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases (Q34767141) (← links)
- Hepatitis A surveillance and vaccine use in China from 1990 through 2007 (Q34989500) (← links)
- Genetic diversity of hepatitis A virus in China: VP3-VP1-2A genes and evidence of quasispecies distribution in the isolates (Q34999311) (← links)
- The effect of policy changes on hepatitis A vaccine uptake in Arizona children, 1995-2008. (Q35040478) (← links)
- Seroprevalence of Hepatitis A Virus Antibodies in the U.S.: Results from the National Health and Nutrition Examination Survey (Q35045744) (← links)
- Changing trends in viral hepatitis-associated hospitalizations in the American Indian/Alaska Native population, 1995-2007 (Q35258162) (← links)
- Hepatitis A virus genotype distribution during a decade of universal vaccination of preadolescents (Q35585415) (← links)
- Determinants of anti-hepatitis A antibody seroprevalence in 2- to 19-year-olds in the USA using NHANES 2007–2008 (Q35701038) (← links)
- Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program (Q35887376) (← links)
- Change in Hepatitis A Seroprevalence among U.S. Children and Adolescents: Results from the National Health and Nutrition Examination Survey 2003-2006 and 2007-2010. (Q35890615) (← links)
- Age-specific seroprevalence of anti-hepatitis a antibody among 1-30 years old population of savadkuh, mazandaran, iran with literature review (Q36075046) (← links)
- Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review (Q36175752) (← links)
- Prevention of hepatitis A by Havrix: a review (Q36238689) (← links)
- Hepatitis A virus: from discovery to vaccines (Q36382222) (← links)
- Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes (Q36421177) (← links)
- Should all children be immunised against hepatitis A? (Q36431979) (← links)
- Epidemiological pattern and mortality rates for hepatitis A in Brazil, 1980-2002--a review (Q36531888) (← links)
- Vaccination against hepatitis A in children: A review of the evidence (Q36663673) (← links)
- Review of 10 years of marketing experience with Chinese domestic inactivated hepatitis A vaccine Healive® (Q36849799) (← links)
- Shifting epidemiology of hepatitis a infection and vaccination status of children aged 6 months-12 years: time for mass vaccination (Q36934533) (← links)
- Hepatitis A vaccination in developing countries: Is Syria next? (Q36970157) (← links)
- Effectiveness of 10-year vaccination (2001-2010) on Hepatitis A in Tianjin, China (Q36977765) (← links)
- Monitoring the impact of vaccines postlicensure: new challenges, new opportunities (Q37150315) (← links)
- Epaxal: a virosomal vaccine to prevent hepatitis A infection (Q37290088) (← links)
- Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program (Q37355475) (← links)
- Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products. (Q37404930) (← links)
- Optimal timing of routine vaccination in HIV-infected persons (Q37439911) (← links)
- Hepatitis A Vaccine Response in Human Immunodeficiency Virus-infected Patients: The Interchangeability of Single Dose versus Double: A Prospective Look (Q37449617) (← links)
- The effects of booster vaccination on combined hepatitis A and hepatitis B vaccine in both anti-HBs and anti-HAV negative children 5-15 years after hepatitis B vaccine primary immunization (Q37521932) (← links)
- Hepatitis A immunity in the District of Aveiro (Portugal): an eleven-year surveillance study (2002-2012). (Q37673146) (← links)
- Viral hepatitis in the elderly (Q37980037) (← links)
- Hepatitis A virus evolution and the potential emergence of new variants escaping the presently available vaccines. (Q37990939) (← links)
- Seroprevalence of hepatitis A virus antibody in a population aged 0-30 years in Shanghai, China: implications for hepatitis A immunization (Q38017820) (← links)
- Diagnostic markers for hepatitis virus infection (Q38089735) (← links)
- Economic analysis of the single-dose immunization strategy against hepatitis A in Argentina (Q38415042) (← links)
- Quantifying the population effects of vaccination and migration on hepatitis A seroepidemiology in Australia. (Q38617154) (← links)
- Impact of the national targeted Hepatitis A immunisation program in Australia: 2000-2014. (Q39162556) (← links)
- A statistical model to estimate the impact of a hepatitis A vaccination programme (Q40044938) (← links)
- Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil. (Q40053249) (← links)
- A dynamic model for assessing universal Hepatitis A vaccination in Canada (Q40251047) (← links)
- Decreasing immunity to hepatitis A virus infection among US adults: Findings from the National Health and Nutrition Examination Survey (NHANES), 1999-2012. (Q40420907) (← links)
- Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis. (Q40932192) (← links)